Finally, promotor hypermethylation of O6–methylguanine-DNA methyltransferase (MGMT) has been found in 0–22% in meningiomas and grade II meningiomas showed twofold higher percentage of MGMT promotor methylation than grade I tumor19–21. Here, MGMT is linked to meningioma.